We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+28.28%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$258M
AUM Growth
-$18.9M
Cap. Flow
-$49M
Cap. Flow %
-19.01%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$104K

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$49.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$43.7B
$68.9M 26.76%
2,577,220
-2,000,620
-44% -$49.1M
TNYA icon
2
Tenaya Therapeutics
TNYA
$163M
$55.2M 21.42%
9,400,290
– –
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$50.1M 19.45%
335,078
– –
NGM
4
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$47M 18.23%
18,136,735
– –
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.44B
$27.7M 10.75%
3,568,181
– –
SRZN icon
6
Surrozen
SRZN
$282M
$5.18M 2.01%
627,653
+11,111
+2% +$104K
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$3.58M 1.39%
172,373
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q2 2023 Portfolio in Review

As of Q2 2023, Column Group held 7 positions worth $258M, down 6.8% from $277M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group withdrew a net $49M in Q2 2023, reducing 1 holding. Its largest reduction was Revolution Medicines, cutting an estimated $49.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Column Group added an estimated $104K to Surrozen.

  • Column Group added most to Surrozen in Q2 2023, an estimated $104K increase.
  • Column Group's biggest Q2 2023 reduction was Revolution Medicines, cutting an estimated $49.1M.
  • Column Group's ten largest holdings make up 100% of its $258M portfolio in Q2 2023.
  • Column Group opened 0 new positions and closed 0 in Q2 2023.
  • Column Group's portfolio value fell 6.8% quarter-over-quarter to $258M.

Based on Column Group's 13F filing for Q2 2023, filed 24 Jul 2023.